Hamilelikte tafluprost kullanmaktan kaçınmalı mıyım? | VeriMom

What to use instead

Pregnancy-safe ingredients that serve a similar function:

Pregnancy-safe products to use instead

Products built around the safer ingredients above, scored "no known risks" or "low risk".

Avero

100

Avero Solid Deodorant

Mew mew tweet

100

Mew mew tweet Cedar Spruce Baking Soda Free

L'Occitane

100

L´Occitane Powder To-mousse Facial Exfoliator

Unknown

100

schmidts here now

Sustain Yourself

100

Sustain Yourself Natural Deodorant

Bitamin

100

Bitamin Natural Deodorant N'orange

Routine

99

Routine Sweet Jane Deodorant Jar

Laura Mercier

99

Laura Mercier Tinted Moisturizer Broad Spectrum Spf 20 - Oil Free

Routine

99

Routine The Curator

bareMinerals

99

bareMinerals Complexion Rescue Tinted Hydrating Gel Cream SPF 30

Hamilelikte tafluprost yerine kullanılabilecek güvenli alternatifler | VeriMom

İçerikler — İçerikler

Ayrıca bakın

• tafluprost hamilelikte güvenli mi?
• tafluprost bebekler için güvenli mi?
• tafluprost için hamilelikte güvenli alternatifler nelerdir?

FAQ

tafluprost hamilelikte güvenli mi?

Tafluprost has a harmonised EU reproductive classification (Repr. 1B, H360 — may damage fertility/ the unborn child) and product/ regulatory labels report animal reproductive toxicity; systemic uterotonic activity of prostaglandin analogues is a plausible mechanism. Systemic exposure from ophthalmic/topical use is low but measurable. (ECHA brief-profile; FDA/TGA product information).

tafluprost emzirirken güvenli mi?

Harmonised H360 reproductive classification and regulatory product information advise caution in pregnancy and breastfeeding; animal reproductive toxicity was observed in non‑clinical studies. Systemic absorption from ophthalmic/topical use is low but measurable, so transfer into breast milk cannot be excluded. (ECHA brief-profile; FDA/TGA product information).

tafluprost bebek cildi için güvenli mi?

H360 harmonised classification indicates reproductive/developmental hazard (h=3). Mechanism (prostaglandin receptor agonism with uterotonic effects) is established. Topical ophthalmic use in adults gives low systemic absorption (e=1); for baby skin exposure increase exposure score by +1 per your rules because infant skin has higher absorption, giving e=2. There are no infant‑specific safety studies for topical/cosmetic use. (ECHA brief-profile; FDA/TGA information).

VeriMom tafluprost nasıl puanlıyor?

VeriMom tafluprost'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 20/100 (yüksek risk) olarak puanlar.

Hamilelikte tafluprost yerine neler kullanılabilir?

Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.